×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 3: The Drug Development Process
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Components of a Global Development Plan
- Development Strategy
- Manufacturing Strategy (CMC Development Plan)
- Risks and Issues
Have an account?